GAS5 and androgen insensitivity syndrome: Lnc‐GAS5 levels were higher in patients with AIS (median [IQR]: 2.509 [1.707–4.369]) than in the controls (median [IQR]: 0.995 [0.707–1.555]; p < 0.001; Figure 1A).